BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6172696)

  • 1. [Hyperthyroidism caused by triiodothyronine (T3-toxicosis)].
    Degrossi OJ; Pinkas M; El Tamer S; Watanabe T; Claus H; García del Rio H
    Medicina (B Aires); 1981; 41(3):337-42. PubMed ID: 6172696
    [No Abstract]   [Full Text] [Related]  

  • 2. T3 toxicosis in adolescence: presentation as recurrent hyperthyroidism.
    AvRuskin TW; Tang S; Shenkman L; Hollander CS
    Pediatrics; 1973 Nov; 52(5):649-52. PubMed ID: 4126724
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent hyperthyroidism presenting as triiodothyronine toxicosis.
    Shenkman L; Mitsuma T; Blum M; Hollander CS
    Ann Intern Med; 1972 Sep; 77(3):410-3. PubMed ID: 4626530
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and biological patterns of hyperthyroidism in elderly patients (author's transl)].
    Chabrier G; Schlienger JL; Stephan F; Reville P
    Sem Hop; 1980 Apr 8-15; 56(13-14):629-34. PubMed ID: 6246589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Triiodothyronine-thyrotoxicosis].
    Lande G; Kjolseth I
    Tidsskr Nor Laegeforen; 1972 Dec; 92(35):2424-7. PubMed ID: 4678982
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study of Basedow's disease with T4 toxicosis].
    Shigemasa C
    Horumon To Rinsho; 1982 Jun; 30(6):603-9. PubMed ID: 6897024
    [No Abstract]   [Full Text] [Related]  

  • 7. Triiodothyronine toxicosis developing during antithyroid drug therapy for hyperthyroidism.
    Hollander CS; Shenkman L; Mitsuma T; Asper SP
    Johns Hopkins Med J; 1972 Aug; 131(2):184-8. PubMed ID: 5068365
    [No Abstract]   [Full Text] [Related]  

  • 8. Laboratory tests for evaluating thyroid therapy.
    Kabadi UM
    Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro diagnosis of T3 thyrotoxicosis].
    Semenov VD
    Med Radiol (Mosk); 1983 Jun; 28(6):72-5. PubMed ID: 6688114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myxedema preceding thyrotoxicosis in Graves' disease.
    Rivera JV; Reyes FM
    Bol Asoc Med P R; 1968 Sep; 60(9):438-42. PubMed ID: 5253699
    [No Abstract]   [Full Text] [Related]  

  • 11. Triiodothyronine-induced thyrotoxicosis in ophthalmic Graves disease.
    Eliopoulos G; Daniels GH; Maloof F
    Arch Intern Med; 1975 Sep; 135(9):1242-4. PubMed ID: 1174301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictor of outcome of hyperthyroidism due to Graves disease: serum triiodothyronine/thyroxine ratio.
    Khanna CM; Shankar LR; Jaggi CB; Bansal JK; Chugh P
    J Assoc Physicians India; 1996 Feb; 44(2):98-101. PubMed ID: 10999059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T3-hyperthyroidism caused by enhanced and shifted T4-conversion.
    Loos U; Keck FS; Grau R
    Horm Metab Res Suppl; 1984; 14():85-93. PubMed ID: 6595195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A more appropriate algorithm of thyroid function test in diagnosis of hyperthyroidism for Thai patients.
    Snabboon T; Sridama V; Sunthornyothin S; Suwanwalaikorn S; Vongthavaravat V
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S19-21. PubMed ID: 16083155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperthyroidism caused by triiodothyronine].
    Pineda G; Stevenson C
    Rev Med Chil; 1973 Sep; 101(9):693-6. PubMed ID: 4130288
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid function during pregnancy in women with past Graves' disease.
    Luton D; Le Gac I; Noel M; Guibourdenche J; Polak M
    BJOG; 2005 Nov; 112(11):1565-7. PubMed ID: 16225580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of triiodothyronine and thyroxine in patients with thyrocardiac disease and their relationship to systolic time intervals.
    Felt V; Cenková V; Nedvídková J
    Endokrinologie; 1982 Nov; 80(3):325-31. PubMed ID: 7166163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thyroxine (T4) to 3,5,3'-triiodothyronine (T3) and 3,3',5'-triiodothyronine (reverse T3) conversion in human leukocyte suspensions. Study in hyper and hypothyroidism states].
    Bianco AC; Nunes MT; Marone MM; Scalissi NM; Correa PH; Douglas CR
    Rev Paul Med; 1984; 102(2):61-4. PubMed ID: 6474031
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of triiodothyronine (T3) measurement].
    De Remigis P; Vianale L; Damiani A; D'Angelo M; Di Roberto A; Sensi S
    Boll Soc Ital Biol Sper; 1982 Jun; 58(11):660-2. PubMed ID: 7115581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.